BioSpace

Foghorn lays off 40% of staff after Lilly collaboration ends

Foghorn Therapeutics and Eli Lilly teamed up in 2021 to develop and commercialize oncology products. The biotech’s layoffs will leave the company with 65 employees as it refocuses on its proprietary portfolio programs.

作者 BioSpace

1 分钟阅读
Foghorn lays off 40% of staff after Lilly collaboration ends
Foghorn lays off 40% of staff after Lilly collaboration ends

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察